IngredientesPollen, the male gametophyte of flowering plants, is collected by honeybees as a primary source of protein and converted into bee pollen through the enzymatic activity of digestive secretions, along with the addition of nectar and bee-derived substances. The primary bee species responsible for commercial bee pollen production is Apis mellifera (the Western honeybee). Bee pollen is a natural cocktail of floral nectar, flower pollen, enzymes, and salivary secretions produced by honeybees. The substance is often referred to in the scientific literature under the broader term apitherapeutic product and is also designated bee-collected pollen or corbicular pollen, reflecting the fact that foraging bees pack floral pollen into the corbicula (pollen baskets) on their hind legs.
The chemical composition of bee pollen depends on the plant, the geographical source, the climatic conditions, the type of soil, and the species of bees that harvest it. As a consequence, bee pollen is not a uniform entity but rather a variable mixture whose composition shifts according to botanical origin. This aspect is frequently overlooked due to the general tendency to treat bee pollen as a uniform entity, despite its inherent chemical diversity. Bee pollen may be monofloral (dominated by pollen from a single plant species) or polyfloral (heterofloral), the latter being the most common commercial form.
Special devices known as pollen traps are used to collect pollen baskets from bees as they return to the hive, causing the bees to shed a portion of their pollen load into a collection tray. Storage conditions materially affect nutritional quality: after 3 months of storage, there was no decrease of ascorbic acid in frozen bee pollen; however, it decreased by 20% in dried bee pollen. Heat during drying may cause thermal decomposition of flavonoids and vitamin C, while even frozen samples are susceptible to slow oxidative processes over extended periods.
Pollen, a remarkably versatile natural compound collected by bees for its abundant source of proteins and nutrients, represents a rich reservoir of diverse bioactive compounds. Its extensive biological effects have been known and exploited since ancient times. The Bible and ancient Egyptian texts are documented proof of its use in public health.
For centuries, bee pollen has attracted increasing scientific interest due to its potential health-promoting properties. It has been used in different countries as a traditional medicine to treat various diseases, including cardiovascular disease, gastric disease, tumors, diabetes, and neurodegenerative disease.
Among documented historical traditions: in ancient civilizations such as Egypt, Greece, and Rome, bee pollen was considered a prized commodity due to its perceived health benefits. It was used to treat a range of ailments, from digestive issues to respiratory problems. The ancient Egyptians reportedly called bee pollen "the powder that gives life," and placed bee products in tombs to nourish the deceased in the afterlife. Ancient Chinese, Egyptian, and Greek civilizations documented the use of bee products, including bee pollen, for their medicinal properties.
In traditional Chinese medicine, bee pollen has long been incorporated into dietary and medicinal regimens. In China, preparations based on rapeseed (Brassica napus) bee pollen have been developed into mainstream pharmaceutical products: Pule'an capsules, which are made entirely from rapeseed bee pollen, have emerged as the prevailing pharmaceutical option for chronic prostatitis and prostate hyperplasia. Clinical trials have shown that Pule'an capsules can effectively alleviate the symptoms of chronic prostatitis and prostate hyperplasia patients, with a symptom relief rate exceeding 90%.
In the context of apitherapy — the use of bee products for therapeutic purposes — bee pollen is used for its medicinal properties, including antimicrobial, anti-inflammatory, antiviral, analgesic, immunostimulant, hepatoprotective, and antioxidant effects.
Over 200 substances have been found in pollen grains from different plant species. In the group of basic chemical substances, there are proteins, amino acids, carbohydrates, lipids and fatty acids, phenolic compounds, enzymes, and coenzymes as well as vitamins and bioelements.
Based on a systematic review of over 100 studies, bee pollen contains an average of 54.22% (range 18.50–84.25%) carbohydrates, 21.30% (range 4.50–40.70%) proteins, 5.31% (range 0.41–13.50%) lipids, 8.75% (range 0.15–31.26%) fibre, and 2.91% (range 0.50–7.75%) ash. Major mineral constituents include potassium (4,951.61 mg/kg average), phosphorus (4,157.86 mg/kg), calcium (1,751.22 mg/kg), and magnesium (1,246.99 mg/kg). These wide ranges reflect substantial variation by botanical and geographic origin.
Pollen contains 22.7% protein on average, including 10.4% of essential amino acids such as methionine, lysine, threonine, histidine, leucine, isoleucine, valine, phenylalanine, and tryptophan. These amino acids are not synthesized in the human body but play an important role in optimal growth and health, and for their vital engagement in gene expression, cell signaling pathways, digestion, and nutrient absorption, they must be included in the diet. Seventeen amino acids, including all nine essential amino acids, have been identified using UHPLC-ESI-MS/MS, accounting for 47–48% of the total amino acid content; arginine, proline, and aspartic acid were the predominant free amino acids.
Fructose, followed by glucose and sucrose, is the major sugar; and nearly 1% of remaining sugars in pollen include arabinose, isomaltose, melibiose, melezitose, ribose, trehalose, and turanose.
Lipids are considered the third group of substances present in bee pollen, after carbohydrates and proteins. Bee pollen is composed of all essential amino and fatty acids, as well as free amino acids, vitamins mainly of the B-complex, essential minerals, carotenoids and flavonoids. Fatty acid fractions include phospholipids, sphingolipids, and triglycerides.
Pollen is a significant source of both fat-soluble vitamins (approximately 0.1%), such as provitamin A and vitamins E and D, and water-soluble vitamins (approximately 0.6%), such as B1, B2, B6, and C, and acids including pantothenic, nicotinic and folic acid, biotin, rutin, and inositol. Their total amount is approximately 0.7% in the whole product. Bioelements are present in about 1.6%, including macronutrients (calcium, phosphorus, magnesium, sodium, and potassium) and micronutrients (iron, copper, zinc, manganese, silicon, and selenium).
The principal phytochemicals found in bee pollen are carotenoids, phenolic acids, and flavonoid aglycones and glycosides, which are established antioxidant health-promoting compounds as well as being responsible for pollen's organoleptic qualities. The phenolic compounds (e.g., flavonoids and phenolic acids) presented in bee pollen are of great interest for the pharmaceutical industry due to their great importance for prophylaxis of diseases, particularly to prevent cardiovascular and neurodegenerative disorders, those having direct correlation with oxidative damage.
Specific phenolic compounds identified across multiple pollen types include: 4-hydroxybenzoic acid, chlorogenic acid, ferulic acid, and gallic acid present as significant phenolic acids, while flavonoids rutin, quercetin, kaempferol, and isorhamnetin are prevalent across different pollen types.
Phytosterols, commonly known as plant sterols, have been shown to inhibit cholesterol absorption sites in the human intestine in multiple clinical trials and also contribute to anticancer effects. A fraction designated as FV-7 in the water-soluble content from the pollen extract Cernilton® was found to inhibit the growth of prostate cancer cell lines.
Bee pollen may also contain alkaloids, including pyrrolizidine alkaloids (PAs) depending on the botanical source of the pollen. Using HPLC-ESI-MS, several saturated and 1,2-dehydropyrrolizidine alkaloids were detected, mainly as their N-oxides, in fresh pollen collected from flowers of the pyrrolizidine alkaloid-producing plants Echium vulgare, E. plantagineum, Senecio jacobaea, S. ovatus, and Eupatorium cannabinum, and/or pollen loads from bees that foraged on those plants. Heating had very little effect on the 1,2-dehydropyrrolizidine alkaloids and their N-oxides. These results strongly indicate a need for monitoring pollen supplies intended for human consumption, at least until conditions for processing and/or selection are clearly defined to significantly reduce their presence.
Studies emphasize bee pollen's strong antioxidant properties, which contribute to cellular protection and overall health by reducing oxidative stress. The quality and antioxidant power of bee pollen is influenced by factors such as the geographical location where it is collected, the specific plants bees forage on, the time of year, weather conditions, and how the pollen is processed. The antioxidant capacity is primarily attributed to the polyphenol content, particularly quercetin, rutin, kaempferol, and related flavonoids.
The mechanism of the anti-inflammatory effect involves inhibiting the activity of cyclooxygenase and lipoxygenase — the enzymes responsible for converting arachidonic acid into prostaglandins and leukotrienes, which induce acute and chronic inflammatory conditions in tissues. At the metabolic and cellular levels, bee pollen phenolics have been reported to modulate intracellular redox homeostasis and inflammatory responses by influencing key signaling pathways, including the regulation of inducible nitric oxide synthase (iNOS) and nuclear factor kappa B (NF-κB) activation. In in vivo studies, pollen was found to have the ability to suppress various inflammatory pathways, including NF-κB and prostaglandin synthesis.
In animal model studies, bee pollen ethanol extract has demonstrated hepatoprotective effects. Supplementing a high-fat diet with bee pollen ethanol extract both at a dose of 1 g/kg body mass and 0.1 g/kg body mass significantly reduced or prevented the development of ballooned hepatocytes in the liver of C57BL/6 mice. A hepatoprotective effect was related to a significant decrease of total cholesterol level (by 31% and 35%) and LDL cholesterol level (by 67% and 90%). These findings are from animal models and have not been directly confirmed in controlled human trials.
The anticancer impact of bee pollen administration is explained by observed underlying mechanisms, such as the stimulation of apoptosis, the inhibition of cell proliferation in multiple cell lines, and the reduction of tumor growth. Lotus (Nelumbo nucifera) bee pollen can induce apoptosis and inhibit the proliferation of human prostate cancer PC-3 cells. These data are from in vitro and/or preclinical studies.
Bee pollen extracts are considered effective against undesirable prostatic conditions due to their anti-inflammatory and anti-androgen properties. One of the most abundant flavonoids in bee pollen, quercetin, lowers inflammation as measured by prostaglandin E2 levels and increases endorphin levels. Quercetin is suggested to play a major role in combating chronic prostatitis by lowering the oxidative stress metabolite F2-isoprostane in patients' expressed prostatic secretions.
This is the most clinically investigated area for bee pollen. In particular, bee pollen has been applied in clinical trials for allergies and prostate illnesses, with a few investigations on cancer and skin problems.
Cernilton® studies (standardized pollen extract): In one study, 90 patients aged 19 to 90 years with chronic prostatitis syndrome received pollen extracts (Cernilton N) in the form of one tablet, three times a day, for 6 months. The patients were categorized into two groups: 72 without any complications and 18 with complications (urethral strictures, prostatic calculi, or bladder neck sclerosis). Overall, 26 (36%) participants with no complicating factors were cured of their symptoms and signs, 56 (78%) had an overall favorable clinical response, and 30 (42%) improved significantly, with an increase in flow rate, decrease in leukocyturia, and a decrease in C3/coeruloplasmin content in the ejaculate.
In a double-blind, placebo-controlled study, 60 individuals with chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CP/CPPS) were randomized to receive either prostate/polit or a placebo for 6 months. Three daily prostate/polit tablets, each containing 74 mg of highly defined pollen extract from Gramineae species, were given. The placebo was identical but without pollen extract. The patients who received prostate/polit tablets healed or improved, in contrast to those who received the placebo, with no adverse effects.
A large multicentre, randomized, prospective, double-blind, placebo-controlled phase 3 study (Wagenlehner et al., European Urology, 2009) evaluated Cernilton in men with inflammatory CP/CPPS. In a placebo-controlled trial with 139 men suffering chronic prostatitis/pelvic pain, the pollen extract significantly improved pain scores and quality of life compared to placebo; approximately 70% of the pollen-treated men had a notable reduction in symptoms versus 50% in the placebo group.
A systematic review covered multiple clinical trials in this area: a review of 10 clinical trials and 590 patients tested the efficacy of different pollen extracts, including bee pollen, for prostate inflammation and pelvic pain. Around 84% of patients responded to the treatment, with significantly improved quality of life and without causing adverse effects.
BPH — HPLE dosage trial: A double-blind, placebo-controlled clinical trial was conducted in 47 patients with benign prostatic hyperplasia (BPH) to investigate the efficacy and safety of 12-week intake of honeybee-collected pollen lump extract (HPLE). Participants were randomly assigned to: placebo (0 mg HPLE/day), lower dose (160 mg HPLE/day), or high dose (320 mg HPLE/day). The maximum urinary flow rate was significantly higher in the high-dose group, while residual urine volume decreased in the high-dose group but increased in the lower-dose and placebo groups. No HPLE-related health risks or clinically significant laboratory abnormalities were found.
In a study of 100 patients with benign prostatic hyperplasia (BPH), a specific bee pollen-based product (Cernilton) improved sexual dysfunction and quality of life. Bee pollen may reduce the need for prostate biopsy in people with elevated prostate-specific antigen (PSA). Among 61 patients, a one-month treatment reduced PSA in those with pelvic inflammation but not in those with prostate cancer.
Evidence assessment: The evidence for pollen extracts (specifically Cernilton-type standardized products) in chronic prostatitis and BPH is among the most robust clinical evidence for any bee pollen application. Multiple randomized controlled trials, including a phase 3 study, show consistent benefit. However, most trials use standardized pharmaceutical extracts (not raw bee pollen), are limited in sample size, and some lack long-term follow-up. The evidence is promising but not yet definitive.
Femal® trial: A randomized, double-blind, placebo-controlled, parallel trial of 64 menopausal women (54 completers) investigated whether Femal, a herbal remedy made from pollen extracts, alleviates menopausal symptoms, especially hot flushes. After an initial run-in phase of 1 month, women were given either two Femal tablets each morning or two identical placebo tablets, for 3 months of treatment. In this trial, a product with bee pollen extracts (Femal) reduced hot flushes in 68% of cases, compared with 32% on placebo, and after three months of treatment, hot flushes dropped by 27% on average.
Breast cancer patients with antihormonal therapy: The utilization of bee pollen and honey in 46 patients over 18 years old with breast cancer receiving antihormonal treatment was reported in a clinical study. The patients were advised to consume a tablespoonful of a pollen and honey mixture for 14 consecutive days. In breast cancer patients receiving antihormonal therapy, honey and bee pollen ameliorated the expected menopausal symptoms. In these 46 women on antihormonal treatment, both bee pollen and honey were more effective than placebo in reducing hot flushes and other symptoms; however, adding bee pollen to honey produced no additional benefits.
Evidence assessment: The clinical evidence for menopausal symptom relief is preliminary. Trials are small, some used bee pollen in combination with other ingredients (making attribution uncertain), and replication in larger independent trials is needed. Bee pollen, alone or combined with other bee products, may reduce hot flushes and other menopausal symptoms, but these findings require verification in larger controlled trials.
Honey bee products, including bee pollen, or their bioactive chemical constituents like polyphenols, demonstrate interesting therapeutic potential in the regulation of inflammatory mediator production as evidenced by modulation of TNF-α, IL-1β, IL-6, IL-2, and IL-7, and the decrease of reactive oxygen species (ROS) production. Additionally, improvement in the immune response via activation of B and T lymphocyte cells, both in vitro, in vivo, and in clinical studies, has been reported.
Animal model studies suggest potential cardiovascular protection. Research on transgenic ApoE-knockout mice predisposed to atherosclerosis suggests that the biochemical mechanism of bee pollen ethanol extract's protective effect against atherosclerosis is related to lowering oxidized LDL (ox-LDL) and ADMA levels and weakening ACE enzyme activity, which results in lowering angiotensin II levels. These data are preclinical only; no adequately powered human cardiovascular trials have been completed.
Evidence for hepatoprotection is currently limited to in vitro and animal studies. Honeybee pollen extracts in hepatocyte cell culture models and animal experiments have demonstrated significant hepatoprotective effect against oxidative damage caused by free radical generators, and some pollen samples show effectiveness in reducing lipid accumulation. Biological activities attributed to bee pollen include hepatoprotective and nephroprotective properties based on preclinical data. No controlled human clinical trials specifically examining liver disease outcomes with bee pollen as the sole intervention have been reported in the reviewed literature.
Recent research has unraveled biological activities associated with bee pollen, ranging from antioxidant, anti-inflammatory, antimicrobial, and antifungal properties. Studies from multiple countries have documented antimicrobial activity of bee pollen extracts against a range of bacterial and fungal strains in vitro. Raw bee pollen samples show significant phenolic acid and flavonoid content with moderate fatty acid, ester, and terpene content, which correlate with observed antimicrobial activity. Antimicrobial evidence is predominantly from in vitro laboratory studies; human clinical evidence is lacking.
Bee pollen has been implicated in combating metabolic disorders such as diabetes, obesity, hyper-dyslipidemia, and related cardiovascular complications. Preclinical and clinical studies have shown that bee pollen presents the capacity to ameliorate biomarkers related to diabetes and obesity. Evidence in this area remains early-stage, and clinical trials are sparse and limited in size.
Bee pollen is a valuable apitherapeutic product. It demonstrates a series of actions including antifungal, antimicrobial, antiviral, anti-inflammatory, hepatoprotective, anticancer, immunostimulating, and local analgesic properties. Beneficial properties of bee pollen and the validity for their therapeutic use in various pathological conditions have been discussed, including the currently known mechanisms by which bee pollen modulates burn wound healing process. Evidence is primarily from animal studies and small clinical observations; robust randomized trials in wound healing are lacking.
Despite longstanding popular claims about bee pollen enhancing athletic performance, research into the therapeutic applications of bee pollen has included clinical trials focusing on allergies and prostate conditions, with some studies exploring effects on cancer and skin issues; however, comprehensive clinical evidence supporting its efficacy across these areas remains limited. The available controlled studies on athletic performance have not demonstrated significant benefit compared to placebo, and these negative findings have been noted in the peer-reviewed literature.
Dosages used in clinical and preclinical studies vary considerably by the form of bee pollen used (raw pollen, standardized extract, or pharmaceutical preparation). The following reflect only figures explicitly reported in the reviewed primary literature:
The appropriate dose of bee pollen depends on several factors such as the user's age, health, and other conditions. At this time there is not enough scientific information to determine a universally appropriate range of doses for raw bee pollen.
While bee products are generally considered safe, they can occasionally cause allergic reactions in sensitive individuals, including potentially life-threatening anaphylaxis. Bee pollen allergy, although relatively rare, can present a life-threatening medical emergency. Conventional treatment of anaphylaxis is indicated, and there is little awareness of this hazard among the general population.
A documented case illustrates the clinical reality: Bee pollen granules are widely consumed as natural healthy supplements. Bee pollen-induced anaphylaxis has rarely been reported. In one case, a 40-year-old male came to the emergency room with generalized urticaria, facial edema, dyspnea, nausea, vomiting, abdominal pain, and diarrhea 1 hour after ingesting one tablespoon of bee pollen.
Bee pollen contains a large amount of pollen belonging to various allergenic families of plants. Bee pollen retains its allergenic potential, as demonstrated by strong cutaneous responses to bee pollen extracts observed in atopic patients in contrast to nonatopic subjects. Further studies are needed to evaluate the safety of ingesting large amounts of bee pollen in pollen-allergic individuals.
Mass spectrometric analysis of bee pollen identified 197 unique proteins derived from plants (Viridiplantae) and 10 unique proteins derived from bees (Apis spp.). Among them, potential plant allergens were discovered. Foods derived from bees can be dangerous to people with allergy to pollen.
Consumption of bee pollen may be associated with the risk of side effects, such as allergic reactions and molds, mycotoxins, pesticides, and toxic metals poisoning. A specific concern involves pyrrolizidine alkaloids: certain plants contain hepatotoxic pyrrolizidine alkaloids, which can end up in bee pollen and pose a risk to consumers if present in high concentrations. As noted above, heating bee pollen during processing does not effectively remove these alkaloids.
A clinically important drug interaction has been documented: consumption of bee pollen led to increased INR values in a patient taking warfarin. The warfarin interaction rating is considered moderate. Bee pollen might increase the effects of warfarin (Coumadin), and taking bee pollen with warfarin might result in an increased chance of bruising or bleeding.
Case reports have linked bee pollen to acute hepatitis: two cases of acute hepatitis after ingestion of herbal preparations were reported; one of the mixtures included chaparral and bee pollen, and the other was pure bee pollen. Chaparral has been reported to have similar effects in other patients, but no prior reports of acute hepatitis from bee pollen were found at the time of reporting. The mechanism in these cases was not definitively established.
Consumption of bee pollen may be associated with the risk of side effects, including molds, mycotoxins, pesticides, and toxic metals poisoning. The botanical diversity of bee pollen means that the contaminant profile varies by source, season, and geography, underscoring the importance of quality control in commercial preparations.
A comparative analysis of raw bee pollen versus fermented bee bread highlights the impact of processing on allergenicity. Processing conditions, drying temperatures, and storage duration all affect both the nutrient profile and the potential allergenicity of commercial bee pollen preparations.
Condiciones de salud que polen de abeja puede ayudar a apoyar.
Bee pollen is rich in polyphenols, flavonoids, and carotenoids that confer potent antioxidant activity. Multiple in vitro and animal studies confirm free-radical scavenging capacity. This is one of the best-documented biological properties of bee pollen across diverse botanical sources.
Bee pollen polyphenols reduce markers of arterial damage including oxidized LDL, angiotensin II, and ACE activity in animal models on high-fat diets. Traditional apitherapy has long included pollen in arterial and circulatory indications, and the German Federal Board of Health recognizes its use in circulatory disorders.
Bee pollen peptides and polyphenols are proposed to inhibit ACE and support antihypertensive pathways. An in vitro study on cardiovascular-disease microbiota found fermented bee pollen elevated lactic and acetic acids — both with known antihypertensive effects. Traditional use for hypertension is also documented.
Bee pollen contains polyphenols and flavonoids that inhibit alpha-glucosidase and alpha-amylase, key enzymes in carbohydrate digestion, potentially lowering postprandial blood glucose. A small human trial in type 2 diabetics showed significant reduction in HbA1c. Animal evidence is strong, though robust human RCTs are limited.
Topical bee pollen ointment has been tested in pig burn wound models, demonstrating reduced healing time, improved tissue histopathology, and antimicrobial efficacy. A Chinese clinical trial specifically evaluated bee pollen-based preparations for burn wound treatment in humans.
Bee pollen polyphenol extracts significantly reduced total cholesterol and LDL in high-fat diet animal models. A human observational study in patients with dyslipidemia showed honey-plus-pollen reduced total cholesterol by 18.3% and LDL by 23.9%. Evidence is preliminary but multi-source.
Bee pollen flavonoids and phenolic compounds inhibit key pro-inflammatory mediators including COX-2, NF-κB, and prostaglandin E2 in cell and animal models. Preliminary human data from menopausal and diabetic populations show reductions in inflammatory markers such as IL-6. Human clinical evidence remains limited but directionally positive.
Buckwheat and apricot bee pollen extracts reduced DSS-induced ulcerative colitis severity in mouse models, modulating Th1/Th2 cytokine balance, reducing ICAM-1 expression, and improving gut microbiota composition. The anti-inflammatory and microbiota-modulating mechanisms are well-characterized at the preclinical level.
Bee pollen contains dietary fibers, polyphenols, and probiotic-associated compounds that demonstrably modulate gut microbial composition in animal and in vitro models. Fermented bee pollen postbiotics increased Lactobacillus and Bifidobacterium while reducing pathogenic E. coli in a cardiovascular disease microbiota model.
Bee pollen is a nutrient-dense bee-collected food containing polyphenols, enzymes, vitamins, and unique flavonoids (kaempferol, quercetin, isorhamnetin) with documented antioxidant, anti-inflammatory, and hepatoprotective effects. Traditional use in multiple cultures links bee pollen consumption to longevity. Human trials show benefits for menopausal symptoms and liver function in aging adults.
Bee pollen has documented anti-atherosclerotic, antihypertensive, and lipid-lowering properties in animal and preliminary human evidence. A PMC review notes it can improve microcirculation and dyslipidemia and may prevent coronary heart disease. Fermented bee pollen postbiotics modulated cardiovascular microbiota in vitro.
Bee pollen exhibits consistent hepatoprotective effects in multiple animal models, protecting against chemical-induced liver damage, reducing liver enzyme elevations (AST, ALT), and reducing hepatic steatosis. In vitro studies confirm protection of liver cell lines (HepG2, Hepa1-6) from oxidative and lipotoxic damage.
Multiple small clinical trials show pollen extracts reduce hot flush frequency, improve sleep, mood, and overall quality of life in peri- and postmenopausal women. A RCT of the pollen-based product Femal found 65% of treated women reported reduction in hot flushes versus 38% on placebo. The evidence is preliminary but consistent.
Bee pollen's phenolic and probiotic content has been shown to reduce fasting blood glucose, body weight gain, liver fat accumulation, and dyslipidemia in animal models — matching all major components of metabolic syndrome. A 2023 PMC scoping review specifically identifies metabolic disorders as a key translational target.
Standardized pollen extracts (Cernilton/Graminex) have been evaluated in multiple clinical trials for benign prostatic hyperplasia (BPH) and chronic prostatitis. A Cochrane review found pollen extract modestly improves urinary symptoms compared to placebo, particularly nocturia. In China, rapeseed bee pollen-based pharmaceutical capsules are a first-line treatment for chronic non-bacterial prostatitis.
Bee pollen ointments have been studied in pig burn wound models and referenced in a Chinese clinical trial for burns. Topical bee pollen reduced healing time, improved tissue histopathology, and demonstrated strong antimicrobial activity against wound pathogens. Traditional use for wound and burn treatment is extensively documented.
Traditional apitherapy and multiple pharmacological reviews cite bee pollen as capable of increasing hemoglobin, red blood cell counts, and iron levels, with applications for pernicious anemia. Scientific evidence is drawn from traditional and pharmacological literature rather than controlled human trials.
Bee pollen has long been used by athletes as an ergogenic aid. Multiple clinical trials, however, found no statistically significant benefit on athletic performance metrics. The relationship is traditional in nature; animal studies show plausible mitochondrial and antioxidant mechanisms but human evidence is negative.
Bee pollen is one of the most widely recognized traditional energy tonics and is extensively used by athletes for perceived energy and stamina. While its B-vitamin, carbohydrate, and protein content provide nutritional rationale, controlled clinical trials have failed to demonstrate objective performance or energy benefits.
Traditional apitherapy systems cite bee pollen for male fertility and vitality. A PMC nanotechnology review states pollen may benefit sterility. Animal studies suggest protective effects on sperm from oxidative damage, but no human clinical trials on male fertility endpoints have been published.
Bee pollen has been traditionally included in formulations aimed at dyslipidemia and cardiovascular wellness. Animal studies show lipid-lowering effects, though triglyceride-specific human evidence is lacking; one mouse study found no significant change in triacylglycerols despite reductions in cholesterol.
Sistemas corporales que polen de abeja puede ayudar a apoyar.
Volver